119 related articles for article (PubMed ID: 21145162)
1. Aspirin non-responder status and early neurological deterioration: a prospective study.
Bugnicourt JM; Roussel B; Garcia PY; Canaple S; Lamy C; Godefroy O
Clin Neurol Neurosurg; 2011 Apr; 113(3):196-201. PubMed ID: 21145162
[TBL] [Abstract][Full Text] [Related]
2. Can aspirin resistance be clinically predicted in stroke patients?
Seok JI; Joo IS; Yoon JH; Choi YJ; Lee PH; Huh K; Bang OY
Clin Neurol Neurosurg; 2008 Feb; 110(2):110-6. PubMed ID: 17964711
[TBL] [Abstract][Full Text] [Related]
3. Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
Karepov V; Tolpina G; Kuliczkowski W; Serebruany V
Cerebrovasc Dis; 2008; 26(3):272-6. PubMed ID: 18648200
[TBL] [Abstract][Full Text] [Related]
4. Aspirin resistance and compliance with therapy.
Dawson J; Quinn T; Rafferty M; Higgins P; Ray G; Lees KR; Walters MR
Cardiovasc Ther; 2011 Oct; 29(5):301-7. PubMed ID: 20553280
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
6. Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke.
Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Lu CH
Clin Neuropharmacol; 2010; 33(1):40-5. PubMed ID: 19855266
[TBL] [Abstract][Full Text] [Related]
7. Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.
Alvarez-Sabín J; Penalba A; Quintana M; Krupinski J; García-Bonilla L; Montaner J
Cerebrovasc Dis; 2009; 28(4):371-7. PubMed ID: 19641312
[TBL] [Abstract][Full Text] [Related]
8. Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome.
Schwammenthal Y; Tsabari R; Shenkman B; Schwartz R; Matetzky S; Lubetsky A; Orion D; Israeli-Korn S; Chapman J; Savion N; Varon D; Tanne D
Cerebrovasc Dis; 2008; 25(4):355-61. PubMed ID: 18305387
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience.
Suri MF; Hussein HM; Abdelmoula MM; Divani AA; Qureshi AI
Med Sci Monit; 2008 Oct; 14(10):PI39-44. PubMed ID: 18830204
[TBL] [Abstract][Full Text] [Related]
10. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
11. Aspirin non-responders in Thai ischemic stroke/TIA patients.
Dharmasaroja P
J Med Assoc Thai; 2008 Jun; 91(6):818-21. PubMed ID: 18697379
[TBL] [Abstract][Full Text] [Related]
12. Comparison of aspirin response measured by urinary 11-dehydrothromboxane B2 and VerifyNow aspirin assay in patients with ischemic stroke.
Dharmasaroja PA; Sae-Lim S
J Stroke Cerebrovasc Dis; 2014; 23(5):953-7. PubMed ID: 24126290
[TBL] [Abstract][Full Text] [Related]
13. Variable platelet response to aspirin in patients with ischemic stroke.
Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
[TBL] [Abstract][Full Text] [Related]
14. "Aspirin resistance" in ischemic stroke: insights using short thrombelastography.
Sambu N; Radhakrishnan A; Englyst N; Weir N; Curzen N
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1412-9. PubMed ID: 23838032
[TBL] [Abstract][Full Text] [Related]
15. Stroke and aspirin non-responder patients: relation with hypertension and platelet response to adenosine diphosphate.
Godeneche G; Sorel N; Ragot S; Chomel JC; Neau JP; Macchi L
Platelets; 2009 Nov; 20(7):471-7. PubMed ID: 19852685
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiologic, rather than laboratory-defined resistance drives aspirin failure in ischemic stroke.
Agayeva N; Gungor L; Topcuoglu MA; Arsava EM
J Stroke Cerebrovasc Dis; 2015 Apr; 24(4):745-50. PubMed ID: 25680657
[TBL] [Abstract][Full Text] [Related]
17. ProFESS trial: any lessons to learn for future anti-platelet trials?
Sharma JC; Vassallo M; Ross IN
Int J Stroke; 2009 Dec; 4(6):458-60. PubMed ID: 19930057
[No Abstract] [Full Text] [Related]
18. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
[TBL] [Abstract][Full Text] [Related]
19. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
[TBL] [Abstract][Full Text] [Related]
20. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
